148 related articles for article (PubMed ID: 7398734)
1. Altered prazosin pharmacokinetics in congestive heart failure.
Baughman RA; Arnold S; Benet LZ; Lin ET; Chatterjee K; Williams RL
Eur J Clin Pharmacol; 1980 Jun; 17(6):425-8. PubMed ID: 7398734
[TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacokinetics of prazosin.
Jaillon P
Clin Pharmacokinet; 1980; 5(4):365-76. PubMed ID: 6994981
[TBL] [Abstract][Full Text] [Related]
3. Influence of congestive heart failure on prazosin kinetics.
Jaillon P; Rubin P; Yee YG; Ball R; Kates R; Harrison D; Blaschke T
Clin Pharmacol Ther; 1979 Jun; 25(6):790-4. PubMed ID: 445945
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and pharmacodynamic studies with prazosin in chronic heart failure.
Silke B; Lakhani ZM; Taylor SH
J Cardiovasc Pharmacol; 1981; 3(2):329-35. PubMed ID: 6166804
[TBL] [Abstract][Full Text] [Related]
5. Clinical pharmacokinetics of prazosin--1985.
Vincent J; Meredith PA; Reid JL; Elliott HL; Rubin PC
Clin Pharmacokinet; 1985; 10(2):144-54. PubMed ID: 3888489
[TBL] [Abstract][Full Text] [Related]
6. Prazosin first-pass metabolism and hepatic extraction in the dog.
Rubin P; Yee YG; Anderson M; Blaschke T
J Cardiovasc Pharmacol; 1979; 1(6):641-7. PubMed ID: 94630
[TBL] [Abstract][Full Text] [Related]
7. Development of pharmacodynamic tolerance to prozosin in congestive heart failure.
Desch CE; Magorien RD; Triffon DW; Blanford MF; Unverferth DV; Leier CV
Am J Cardiol; 1979 Nov; 44(6):1178-82. PubMed ID: 495512
[TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacology of prazosin in hypertensive patients with chronic renal failure.
Chaignon M; Le Roux E; Aubert P; Lucsko M; Safar M; Flouvat B; Guedon J
J Cardiovasc Pharmacol; 1981; 3(1):151-60. PubMed ID: 6160344
[TBL] [Abstract][Full Text] [Related]
9. Haemodynamic effects of a single low dose of prazosin in patients with chronic congestive cardiac failure correlations with pharmacokinetics.
Horowitz JD; Dynon MK; Jarrott B; Brennan JB; Oliver LE; Goble AJ; Louis WJ
Clin Exp Pharmacol Physiol; 1984; 11(1):7-15. PubMed ID: 6713738
[TBL] [Abstract][Full Text] [Related]
10. Increase in plasma norepinephrine during prazosin therapy for chronic congestive heart failure.
Stein L; Henry DP; Weinberger MH
Am J Med; 1981 Apr; 70(4):825-32. PubMed ID: 7011023
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of prazosin effect on cardiac output in chronic heart failure.
Arnold SB; Williams RL; Ports TA; Baughman RA; Benet LZ; Parmley WW; Chatterjee K
Ann Intern Med; 1979 Sep; 91(3):345-9. PubMed ID: 475164
[TBL] [Abstract][Full Text] [Related]
12. Prazosin kinetics in essential hypertension.
Chau NP; Flouvat BL; Le Roux E; Safar ME
Clin Pharmacol Ther; 1980 Jul; 28(1):6-11. PubMed ID: 7389255
[TBL] [Abstract][Full Text] [Related]
13. Prazosin and hydralazine in congestive heart failure. Regional hemodynamic effects in relation to dose.
Magorien RD; Triffon DW; Desch CE; Bay WH; Unverferth DV; Leier CV
Ann Intern Med; 1981 Jul; 95(1):5-13. PubMed ID: 7247126
[TBL] [Abstract][Full Text] [Related]
14. Prazosin kinetics and effectiveness in renal failure.
Lowenthal DT; Hobbs D; Affrime MB; Twomey TM; Martinez EW; Onesti G
Clin Pharmacol Ther; 1980 Jun; 27(6):779-83. PubMed ID: 7379445
[TBL] [Abstract][Full Text] [Related]
15. Prazosin disposition in young and elderly subjects.
Rubin PC; Scott PJ; Reid JL
Br J Clin Pharmacol; 1981 Sep; 12(3):401-4. PubMed ID: 7295470
[TBL] [Abstract][Full Text] [Related]
16. Ambulatory prazosin treatment of chronic congestive heart failure: development of late tolerance reversible by higher dosage and interrupted substitution therapy.
Awan NA; Lee G; DeMaria AN; Mason DT
Am Heart J; 1981 May; 101(5):541-7. PubMed ID: 7223594
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of terazosin.
Sonders RC
Am J Med; 1986 May; 80(5B):20-4. PubMed ID: 2872802
[TBL] [Abstract][Full Text] [Related]
18. Effects of red rest and prazosin in congestive heart failure.
Thaulow E; Ihlen H; Kjekshus J; Forfang K; Storstein O
Acta Med Scand; 1982; 212(3):131-6. PubMed ID: 7148503
[TBL] [Abstract][Full Text] [Related]
19. Acute hemodynamic and long-term clinical effects of prazosin in the treatment of chronic congestive heart failure.
von der Lippe G; Ohm OJ; Lund-Johansen P
Acta Med Scand; 1981; 210(3):213-6. PubMed ID: 7293839
[TBL] [Abstract][Full Text] [Related]
20. Dynamic responses to continuous use of prazosin and hydralazine in patients with refractory heart failure.
Elkayam U; Mathur M; Frishman W; LeJemtel T; Strom J; Sonnenblick EH
Clin Pharmacol Ther; 1981 Jul; 30(1):23-30. PubMed ID: 7237894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
